Efficacy and Safety Study of Catheter Ablation for Atrial Fibrillation

NCT01113294 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2040

Last updated 2010-04-29

No results posted yet for this study

Summary

To compare the efficacy of different procedures, identify the optimal procedure, ablation sites, ablation endpoints and post-operative anticoagulation strategy, establish the optimal treatment strategy for atrial fibrillation.

Conditions

Interventions

PROCEDURE

catheter ablation

circumferential pulmonary vein isolation complex fractionated atrial electrograms ablation circumferential pulmonary vein isolation combined left atrial roof ablation circumferential pulmonary vein isolation combined left atrial isthmus ablation circumferential pulmonary vein isolation combined left atrial roof and isthmus ablation circumferential pulmonary vein isolation combined complex fractionated atrial electrograms ablation

Sponsors & Collaborators

  • Peking Union Medical College

    collaborator OTHER
  • Shanghai Chest Hospital

    collaborator OTHER
  • Nanjing Medical University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • Dalian Medical University

    collaborator OTHER
  • Capital Medical University

    collaborator OTHER
  • Wuhan University

    lead OTHER

Principal Investigators

  • Cong-xin Huang, doctor · Renmin Hospital of Wuhan University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113294 on ClinicalTrials.gov